Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Market Cap
Evolus has a market cap or net worth of 446.26 million as of July 16, 2025. Its market cap has decreased by -17.54% in one year.
Market Cap
446.26M
Enterprise Value
492.78M
Revenue
213.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.58
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from 194.93M to 446.26M, an increase of 128.93%. That is a compound annual growth rate of 11.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 165.33B |
GSK plc | 57.64B |
Haleon | 32.65B |
Smith & Nephew | 9.62B |
ConvaTec Group | 5.29B |
Hikma Pharmaceuticals | 4.35B |
HUTCHMED (China) | 2.09B |
Genus | 1.47B |